Fundamental dimension Equity attribute | CACLeader $57.84▼-0.03% Cap $977.3MP/E 11.0x QuantScore64/100 | ACNBPeer $65.42▲+0.05% Cap $665.3MP/E 12.1x QuantScore59/100 | CCBGPeer $50.53▲+0.08% Cap $864.7MP/E 13.8x QuantScore53/100 |
|---|---|---|---|
1. QuantScore pillars0–100 per pillar · click a ticker for the factor breakdown | |||
Technical | |||
93/100 |
94/100 |
93/100 |
Valuation Multiples, PEG & DCF upside | 96/100 | 96/100 | 78/100 |
Health Piotroski, Altman Z, leverage & liquidity | 29/100 | 33/100 | 53/100 |
Growth Revenue / earnings growth & margins | 58/100 | 55/100 | 42/100 |
Sentiment Analyst ratings, targets & revisions | 45/100 | 20/100 | 0/100 |
2. Valuation multiples & capital pricingGreen highlight = best-in-class (lowest positive multiple) |
Trailing P/E | 11.0x | 12.1x | 13.8x |
Forward P/E (next FY) | 10.8x | 11.6x | 13.3x |
EV / EBITDA (TTM) | 14.6x | 13.1x | 9.8x |
Price / Sales | 2.8x | 3.3x | 3.1x |
Price / Free Cash Flow | 9.5x | 12.3x | 12.4x |
PEG ratio | 0.17 | 0.19 | 5.48 |
3. Financial health & solvencyLatest filings |
Piotroski F-Score | 7 / 9 | 8 / 9 | 8 / 9 |
Altman Z-Score | 0.23 (Distress) | 0.36 (Distress) | 0.44 (Distress) |
Total debt / equity | 0.79 | 0.80 | 0.13 |
Quick ratio | 0.2x | 0.2x | 1.8x |
Interest coverage | 0.8x | 1.8x | 2.7x |
4. Growth & margins trajectoryLatest fiscal year |
Revenue growth YoY | +26.8% | +28.9% | +6.5% |
Net income growth YoY | +22.9% | +16.3% | +16.3% |
Gross margin (TTM) | 67.4% | 79.6% | 91.0% |
Operating margin (FY) | 22.2% | 27.3% | 30.0% |
FCF margin (FY) | 15.8% | 30.9% | 28.7% |
5. Trailing price performancePrice change over period |
1M return | +0.0% | +2.7% | +1.3% |
3M return | +5.9% | +5.3% | -2.1% |
6M return | +16.4% | +33.3% | +9.5% |
Year to date | +33.3% | +35.3% | +18.7% |
1Y return | +55.8% | +46.8% | +25.3% |
3Y return | +110.7% | +104.4% | +88.0% |
6. DCF valuation & street consensusDCF model · analyst consensus |
DCF model fair value | $112.91 +95.2% upside | $83.40 +27.5% upside | $64.95 +28.5% upside |
Wall Street consensus target | $59.00 +2.0% · range $58.00–$60.00 | $61.00 -6.8% · range $57.00–$65.00 | $39.75 -21.3% · range $30.00–$49.50 |
Consensus stance | 67% Buy33% Hold0% Sell | 50% Buy50% Hold0% Sell | 14% Buy86% Hold0% Sell |